1 in 3 adults suffer from pre-diabetes. They have an increased risk of diabetes due to a disconnect from personalized, simple health data
SynchNeuro, Inc. has developed a non-invasive CGM that converts brain signals to glucose levels
Bringing clarity from complex information, for actionable metabolic well-being
Primary research
To understand the domain and current situation
Physical + Digital
tools
Patients + Healthcare
professionals
Systematic deconstruction
Breaking down into layers of functional clusters, which directly affect pre-diabetic health
Functions wrt UX
Categories
Terminologies
AI-generated data
Qualitative
Focus Group
MUST
Quantitative
Real-time Survey
SUS
63%
found health-related copy too clinical, yet approved terminologies
Behavior linked tips
were preferred over generic ones, especially for AI predictions of glucose levels
9 of 10
faced navigation issues in at least one task
Addressed 75% improvement in usability, with the design going hand-in-hand on the company strategy and goals. Currently in production and user testing, soon to be launched!
On to the next big thing..
Reach out to me